Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 11, Issue Suppl 1
1268 Eruptive keratoacanthomas secondary to nivolumab therapy
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
1268 Eruptive keratoacanthomas secondary to nivolumab therapy
Online download statistics by month:
Online download statistics by month: November 2023 to November 2024
Abstract
Full
Pdf
Nov 2023
96
0
10
Dec 2023
44
0
7
Jan 2024
57
0
11
Feb 2024
28
0
7
Mar 2024
48
0
8
Apr 2024
42
0
4
May 2024
28
0
6
Jun 2024
50
0
4
Jul 2024
44
0
8
Aug 2024
24
0
2
Sep 2024
40
0
3
Oct 2024
16
0
6
Nov 2024
38
0
6
Total
555
0
82
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF